All news

With potential to impact millions, study finds that biomimetic materials pulsed with low-energy blue light can reshape damaged corneas, including thickening the tissue.

The comprehensive screening platform and cellular interrogation tool has the potential to facilitate novel drug discovery targeting a slew of human diseases.

The Heart & Stroke Foundation of Canada (Heart & Stroke) named four researchers from the University of Ottawa Heart Institute recipients of project funding through its Grant-in-Aid Program.

We need lab research to understand the diseases of today and find the treatments of tomorrow. But like other areas of healthcare, it creates a lot of waste and uses a lot of energy.

Canadians with biliary tract cancer (cholangiocarcinoma and gallbladder) will have the first chance to benefit from a new made-in-Canada approach to personalized cellular immunotherapy, thanks to a $7.4 million grant from the Canadian Cancer Society and the Canadian Institutes of Health Research.

Researchers from the uOttawa Faculty of Medicine and affiliated institutes have attracted more than $22 million in the latest funding allocations from the Canadian Institutes of Health Research (CIHR).

Research led by Dr. Marc-André Langlois describes an against-the-grain discovery that could show the way forward for HIV cure research.

Dr. Marceline Côté’s team found a new viral entry for SARS-CoV-2 and suggests it may be able to use proteins to infect a wider range of cells.

Dr. Benjamin Rotstein and collaborators unveil an operationally simple method to prepare carbon isotope-labeled versions of drugs and diagnostics.

Dr. Benjamin Rotstein and collaborators unveil an operationally simple method to prepare carbon isotope-labeled versions of drugs and diagnostics.